Richard M. Shepard

2.6k citations
28 papers · 2.0k indexed · 1 hit paper · h-index 18
Topics
Vitamin D Research Studies (5 papers)Immunotherapy and Immune Responses (4 papers)Antibiotics Pharmacokinetics and Efficacy (4 papers)
Partner nations
United States

In The Last Decade

Richard M. Shepard

26 papers receiving 1.9k citations

Hit Papers

The pharmacokinetics of azithromycin in human serum and t...19902026200220141990200400600

Peers

Richard M. Shepard
Comparison fields: 5 of 119
  • Pathology and Forensic Medicine 595
  • Epidemiology 526
  • Pharmacology 340
  • Molecular Biology 238
  • Infectious Diseases 234
Replace Mary J. Kennett with:
Mary J. Kennett United States
Temitope O. Keku United States
Hee‐Bom Moon South Korea
Tomoyuki Tsujikawa Japan
Yasuhiro Kawai Japan
Banu Sancak Türkiye
Steven B. Porter United States
André M. Cantin Canada
Rosário Dominguez Crespo Hirata Brazil
Yohei Mizuta Japan
Richard M. Shepard relative to Mary J. Kennett United States Mary J. Kennett's profile →
Citations per field
00.5×1.7×
Mary J. Kennett · 1×
Citations per year

Countries citing papers authored by Richard M. Shepard

Since Specialization
Citations

This map shows the geographic impact of Richard M. Shepard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard M. Shepard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard M. Shepard more than expected).

Fields of papers citing papers by Richard M. Shepard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard M. Shepard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard M. Shepard. The network helps show where Richard M. Shepard may publish in the future.

Co-authorship network of co-authors of Richard M. Shepard

This figure shows the co-authorship network connecting the top 25 collaborators of Richard M. Shepard. A scholar is included among the top collaborators of Richard M. Shepard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard M. Shepard. Richard M. Shepard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 55
2 18
3 33
4 15
5 59
6 8
7
Preclinical Toxicology Studies with Azithromycin. Acute and Subchronic Studies in Rodents.
1
8
Preclinical toxicology studies in beagle dogs with azithromycin
1
9 3
10 11
11 27
12 80
13 88
14 35
15 118
16
The pharmacokinetics of azithromycin in human serum and tissuesbreakdown →
627
17 2
18 117
19 157
20 2

About Richard M. Shepard

Richard M. Shepard is a scholar working on Pharmacology, Cell Biology and Behavioral Neuroscience, having authored 28 papers that have together received 2.0k indexed citations. Recurring topics across this work include Vitamin D Research Studies (5 papers), Immunotherapy and Immune Responses (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (595 citations), Molecular Medicine (130 citations) and Microbiology (133 citations). Richard M. Shepard has collaborated with scholars based in United States. Frequent co-authors include George Foulds, Hector F. DeLuca, Raymond B. Johnson, Ronald L. Horst, Alan J. Hamstra, Fred C. Falkner, John A. Eisman, Jack S. Remington, Fausto G. Araujo and Michelle Mullins. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026